Literature DB >> 19889451

Pulmonary embolism in pregnancy.

Ghada Bourjeily1, Michael Paidas, Hanan Khalil, Karen Rosene-Montella, Marc Rodger.   

Abstract

Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world. Mortality from PE in pregnancy might be related to challenges in targeting the right population for prevention, ensuring that diagnosis is suspected and adequately investigated, and initiating timely and best possible treatment of this disease. Pregnancy is an example of Virchow's triad: hypercoagulability, venous stasis, and vascular damage; together these factors lead to an increased incidence of venous thromboembolism. This disorder is often suspected in pregnant women because some of the physiological changes of pregnancy mimic its signs and symptoms. Despite concerns for fetal teratogenicity and oncogenicity associated with diagnostic testing, and potential adverse effects of pharmacological treatment, an accurate diagnosis of PE and a timely therapeutic intervention are crucial. Appropriate prophylaxis should be weighed against the risk of complications and offered according to risk stratification. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889451     DOI: 10.1016/S0140-6736(09)60996-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

1.  Embolectomy for massive pulmonary embolism after cesarean delivery.

Authors:  Ki Hoon Ahn; Soon-Cheol Hong
Journal:  CMAJ       Date:  2015-09-21       Impact factor: 8.262

2.  Outcomes of negative multidetector computed tomography with pulmonary angiography in pregnant women suspected of pulmonary embolism.

Authors:  Ghada Bourjeily; Hanan Khalil; Christina Raker; Susan Martin; Pauline Auger; Michel Chalhoub; Lucia Larson; Margaret Miller
Journal:  Lung       Date:  2011-10-18       Impact factor: 2.584

3.  Diagnosing venous thromboembolism in pregnancy.

Authors:  Thomas Grüning; Rebecca E Mingo; Matthew G Gosling; Sally L Farrell; Brent E Drake; Robert J Loader; Richard D Riordan
Journal:  Br J Radiol       Date:  2016-04-08       Impact factor: 3.039

4.  Novel Thoracic MRI Approaches for the Assessment of Pulmonary Physiology and Inflammation.

Authors:  Jonathan P Brooke; Ian P Hall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  PURL: Ruling out PE in pregnancy.

Authors:  Jennifer Svarverud; Pamela Hughes
Journal:  J Fam Pract       Date:  2020-10       Impact factor: 0.493

Review 6.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

7.  Favorable outcome under anticoagulant therapy in a high risk pregnancy case report and short review of the (recent) literature.

Authors:  Irina Voican; Prof Ana Maria Vladareanu; Minodora Onisai; Anca Nicolescu; Prof Radu Vladareanu
Journal:  Maedica (Buchar)       Date:  2012-12

Review 8.  Imaging of acute pulmonary embolism.

Authors:  Maria Komissarova; Suzanne Chong; Kirk Frey; Baskaran Sundaram
Journal:  Emerg Radiol       Date:  2012-11-14

9.  Recombinant tissue plasminogen activator for massive pulmonary thromboembolism.

Authors:  Kouki Samejima; Yasushi Takai; Hideyoshi Matsumura; Hiroyuki Seki
Journal:  BMJ Case Rep       Date:  2013-05-23

10.  [Radiology and pregnancy : Part 2: clinical recommendations].

Authors:  G Weisser; V Steil; K W Neff; K A Büsing
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.